IntriCon Corporation (NASDAQ: IIN)
, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, announced that its strategic partner, Minneapolis-based Advanced Medical Electronics Corp. (AME), is participating in two new research grants from the U.S. Government.
The first, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), supports development of an ultra-miniature, body-worn technology platform for recording signals from skin electrodes. This core capability can be applied to:
- electrocardiography (ECG), measuring the heart’s electrical activity;
- electromyography (EMG), gauging the electrical activity of skeletal muscles;
- electroencephalography (EEG), measuring electrical activity in the brain; and
- skin impedance recording, measuring electrical and temperature changes at the skin’s surface.
In addition to further development of this core recording platform, the grant will support testing and Food and Drug Administration (FDA) submission.
“The funding that AME received will be used to further advance and commercialize our ultra-low power PhysioLink™ wireless technology platform,” said Mark S. Gorder, president and chief executive officer of IntriCon. “This includes aggressive development of the electronics and device enclosure that will comprise our next-generation ambulatory ECG products, among other body-worn monitoring applications.”
In addition to the NIBIB funding, AME also is a collaborator on a grant from the National Institute on Disability and Rehabilitation Research (NIDRR). This phase-one grant is for additional research and feasibility testing for solid-state sensor technology that will ultimately replace aging telecoil sensor technology in hearing aids.
Said Gorder, “Ultimately, this funding will allow AME and IntriCon to explore the possibility of creating hearing aid devices that work better with personal electronics such as land-line and mobile phones, iPods and other listening devices. Right now hearing aid users have to orient their head or the device to achieve the optimal signal—and that can be problematic at best. New technology will eliminate that and also result in smaller overall devices.”